All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can get involved.
COVID-HEME is a peer-to-peer forum for physicians about the care of patients with hematologic malignancies during the COVID-19 pandemic. The goal of this collaborative platform is to improve and accelerate the knowledge and experience of physicians to optimize the management of patients during the pandemic.
To join COVID-HEME, please ask for an invitation at firstname.lastname@example.org
COVID-HEME forum supports hematologists during COVID-19 pandemic
Alemtuzumab plus CHOP in elderly patients with PTCL: Results from a phase III trial
Despite recent efforts to improve outcomes, survival in patients with peripheral T-cell lymphoma (PTCL) remains poor. First-line treatment for the most common PTCL...
Management of COVID-19 outbreak on transplant wards
An article based on a webinar arranged by the EBMT and ASTCT titled “Strategies to prevent and handle outbreak of COVID-19 on transplant wards”.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox